| Press Releases
 2008
Archive
Conferences
Media Contact
Mailing List
|
 Archive
of WILEX Press Releases
Selected press releases of the former years can be found
here.
2007
2006
2005
2004
2003
2002 and earlier
- 28 November 2002
- Study on clinical Phase II trial with antibody cG250 against renal
cell carcinoma receives Clinical Science Award 2002
- 20 November 2002
- WILEX receives
Drug Manufacturing Permission and international GLP certification
from German authorities (German only)
- 14 October 2002
- WILEX initiates
first clinical trial for Urokinase Inhibitor WX-UK1 in cancer patients
- 09 April 2002
- WILEX's WX-G250 renal cancer therapeutic shows clinical
benefit in Phase II trial
- 08 April 2002
- WILEX receives Orphan Drug Designation in Europe for WX-G250
- 18 March 2002
- WILEX reports positive Phase Ia clinical data on its anti-metastatic
Urokinase Inhibitor WX-UK1
- 04 March 2002
- WILEX appoints members to its Scientific Advisory Board
|  |
